Helsinn

Home > Irish Pharmaceuticals > News > News 2008

12/12/2008	HELSINN HEALTHCARE AND ZEALAND PHARMA SIGN A PARTNERING AGREEMENT FOR ZP1846, A NOVEL GLP-2 AGONIST
10/12/2008	Helsinn Birex Pharmaceuticals receives IMP Licence for storage and packaging of Clinical Trial Materials
12/09/2008	PALONOSETRON: THE LONG-LASTING ANTIEMETIC ACTION FINDS ITS BASIS
25/08/2008	HELSINN HEALTHCARE SA ANNOUNCES THE FDA’S APPROVAL OF ALOXI® (PALONOSETRON HCI) CAPSULES FOR PREVENTION OF ACUTE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
22/07/2008	SUCCESSFUL INSPECTION OF HELSINN BIREX PHARMACEUTICALS DUBLIN, IRELAND BY THE US FOOD AND DRUG ADMINISTRATION
09/07/2008	HELSINN HEALTHCARE SA ANNOUNCES THE LAUNCH OF ALOXI® (PALONOSETRON HCL) INJECTION FOR THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN THE USA
02/07/2008	Helsinn Chemical Operations started activities with the UK distributor Alfa Chemicals Ltd.
02/07/2008	Helsinn Chemical Operations started activities with the UK distributor Alfa Chemicals Ltd.
16/06/2008	POSITIVE OUTCOME TO HELSINN’S PARTICIPATION IN THE 2008 ASCO ANNUAL MEETING - Chicago, USA, 30 May – 3 June 2008 -
08/05/2008	HELSINN TO PRESENT AT THE RODMAN & RENSHAW 5th ANNUAL GLOBAL HEALTHCARE CONFERENCE MONTE CARLO, MONACO, May 19th 2008
14/04/2008	HELSINN HEALTHCARE STREAMLINES QUALITY ASSURANCE GLOBALLY WITH SPARTA SYSTEMS’ TRACKWISE SOFTWARE
03/03/2008	FDA APPROVES ALOXI® (PALONOSETRON HCL) INJECTION FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING
20/02/2008	HELSINN’S PARTICIPATION IN INFORMEX 2008
11/02/2008	HELSINN HEALTHCARE SA ANNOUNCES THE LAUNCH OF ALOXI® (PALONOSETRON) IN THE UK
03/01/2008	HELSINN AND MGI PHARMA ANNOUNCE sNDA FOR ALOXI CAPSULES ACCEPTED FOR REVIEW BY U.S. FDA